Bayesian analysis of a disability model for lung cancer survival
暂无分享,去创建一个
C Armero | S Cabras | ME Castellanos | S Perra | A Quirós | MJ Oruezábal | J Sánchez-Rubio | C. Armero | S. Cabras | S. Perra | J. Sánchez-Rubio | A. Quiros | M. Castellanos | M. Oruezábal | M. E. Castellanos | Carmen Armero | Silvia Perra | Alicia Quirós
[1] Y. Soon,et al. Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Jim Albert,et al. Bayesian Computation with R , 2008 .
[3] A. F. Stewart. Hypercalcemia Associated with Cancer , 2005 .
[4] N. Keiding,et al. Multi-state models for event history analysis , 2002, Statistical methods in medical research.
[5] Maja Pohar Perme,et al. Inference for outcome probabilities in multi-state models , 2008, Lifetime data analysis.
[6] V T Farewell,et al. A multi‐state model for joint modelling of terminal and non‐terminal events with application to Whitehall II , 2007, Statistics in medicine.
[7] E. Brambilla,et al. The evolving role of histology in the management of advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] J P Klein,et al. Multi‐state models and outcome prediction in bone marrow transplantation , 2001, Statistics in medicine.
[9] N. Malats,et al. A dynamic model for the risk of bladder cancer progression , 2012, Statistics in medicine.
[10] P Hougaard,et al. Multi-state Models: A Review , 1999, Lifetime data analysis.
[11] L. Sharples,et al. Predicting Survival in Potentially Curable Lung Cancer Patients , 2008, Lung.
[12] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[13] A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer , 2005, British Journal of Cancer.
[14] Ardo van den Hout,et al. Multi‐state analysis of cognitive ability data: A piecewise‐constant model and a Weibull model , 2008, Statistics in medicine.
[15] I. G. Evans,et al. Bayesian prediction for two-parameter weibull lifetime models , 1980 .
[16] A. Raftery,et al. Bayesian Information Criterion for Censored Survival Models , 2000, Biometrics.
[17] B. Jeremic,et al. Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy , 2003, Journal of Cancer Research and Clinical Oncology.
[18] R. Doll. The Age Distribution of Cancer: Implications for Models of Carcinogenesis , 1971 .
[19] J. Klein,et al. Survival Analysis: Techniques for Censored and Truncated Data , 1997 .
[20] Thomas Kneib,et al. Bayesian semi parametric multi-state models , 2008 .
[21] Arnold Knijn,et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. , 2009, European journal of cancer.
[22] J. Berger. The case for objective Bayesian analysis , 2006 .
[23] K. Eguchi,et al. Hypercalcemia-leukocytosis syndrome associated with lung cancer. , 2004, Lung cancer.
[24] A. Rossi,et al. The emerging role of histology in the choice of first-line treatment of advanced non-small cell lung cancer: implication in the clinical decision-making. , 2010, Current medicinal chemistry.
[25] D Oakes,et al. Multiple time scales in survival analysis , 1995, Lifetime data analysis.
[26] Yohann Foucher,et al. A semi-Markov model for multistate and interval-censored data with multiple terminal events. Application in renal transplantation. , 2007, Statistics in medicine.
[27] J. Klein,et al. Statistical Models Based On Counting Process , 1994 .
[28] Ardo van den Hout,et al. Estimating dementia-free life expectancy for Parkinson's patients using Bayesian inference and microsimulation , 2009, Biostatistics.
[29] Peter Green,et al. Markov chain Monte Carlo in Practice , 1996 .
[30] Joseph G. Ibrahim,et al. Bayesian Survival Analysis , 2004 .
[31] Michael C. Minnotte,et al. Noncancer deaths in white adult cancer patients. , 1993, Journal of the National Cancer Institute.
[32] Michael J Pencina,et al. Choice of time scale and its effect on significance of predictors in longitudinal studies , 2007, Statistics in medicine.
[33] Carmen Cadarso-Suárez,et al. Multi-state models for the analysis of time-to-event data , 2009, Statistical methods in medical research.
[34] H Putter,et al. Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.